Free Trial
→ $100 Trillion “AI Metal” Found in American Ghost Town (From Brownstone Research) (Ad) Free NLSP Stock Alerts

NLS Pharmaceutics (NLSP) SEC Filings & 10K Form

NLS Pharmaceutics logo
$2.20 +0.07 (+3.29%)
Closing price 07/15/2025 03:59 PM Eastern
Extended Trading
$2.21 +0.01 (+0.45%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/01/2025
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
6:31 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2025
3:57 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SCHEDULE 13D
06/23/2025
4:29 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
06/16/2025
6:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2025
6:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
06/10/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2025
7:54 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
05/01/2025
8:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form NT 20-F
04/15/2025
8:05 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
8:07 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
04/14/2025
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2025
4:23 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
03/31/2025
9:24 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
03/31/2025
8:29 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:20 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:52 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/30/2024
5:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad)

Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.

Click here to see the details on what could be the biggest tech story of this decade.
12/23/2024
3:04 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K/A
12/03/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
11:15 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
3:30 PM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/26/2024
3:40 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSP) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Central Banks Are Hoarding Gold – Should You?
The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...
Lear Capital | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
All New Social Security Numbers coming July 23?
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...
Golden Portfolio | Sponsored
Why Elon is funding the “Quantum Power Grid”
Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...
True Market Insiders | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored